Alibaba
BABA
NVIDIA
NVDA
Cisco
CSCO
Netflix
NFLX
Apple
AAPL
US Stock MarketDetailed Quotes
ENTA Enanta Pharmaceuticals
- 7.140
- -0.360-4.80%
Close Feb 14 16:00 ET
- 7.140
- 0.0000.00%
Post 20:01 ET
152.31MMarket Cap-1.44P/E (TTM)
7.680High7.080Low419.30KVolume7.500Open7.500Pre Close3.07MTurnover2.80%Turnover RatioLossP/E (Static)21.33MShares17.80052wk High1.36P/B107.10MFloat Cap4.71052wk Low--Dividend TTM15.00MShs Float127.770Historical High--Div YieldTTM8.00%Amplitude4.710Historical Low7.310Avg Price1Lot Size
Enanta Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 32.76%-16.8M | 23.64%-78.76M | 51.86%-10.4M | 54.01%-14.78M | -107.51%-28.6M | 29.89%-24.99M | -21.67%-103.15M | -39.06%-21.6M | -8.53%-32.13M | 47.74%-13.78M |
| Net income from continuing operations | 33.28%-22.29M | 13.28%-116.05M | -2.55%-28.82M | 42.00%-22.66M | 17.26%-31.16M | -15.25%-33.41M | -9.91%-133.82M | -6.68%-28.11M | -23.23%-39.07M | -12.10%-37.66M |
| Operating gains losses | --6K | -89.33%16K | ---- | ---- | ---- | ---- | --150K | --143K | --0 | ---- |
| Depreciation and amortization | 38.47%889K | -1.48%2.34M | -28.40%479K | -8.76%594K | 15.00%621K | 25.64%642K | -20.25%2.37M | 2.14%669K | -9.08%651K | -34.31%540K |
| Other non cash items | -331.17%-1.82M | 140.85%2.14M | 131.37%2.25M | -129.91%-588K | ---304K | --786K | -464.37%-5.24M | -8,534.94%-7.17M | 4,568.18%1.97M | ---- |
| Change In working capital | 108.18%113K | -11.14%7.13M | 47.62%9.16M | 318.93%2.7M | -119.67%-3.35M | 90.10%-1.38M | 18.19%8.02M | 84.98%6.21M | 80.67%-1.23M | 13,186.92%17.01M |
| -Change in receivables | -424.91%-1.52M | -89.67%973K | -61.74%1.99M | -147.95%-844K | -97.46%120K | 87.17%-289K | -20.15%9.42M | 726.18%5.19M | 336.88%1.76M | -47.19%4.72M |
| -Change in prepaid assets | 9,505.56%1.73M | 367.03%850K | -25.24%2.85M | -67.30%-4.33M | -33.19%2.31M | 100.40%18K | -75.50%182K | 299.90%3.81M | -201.93%-2.59M | 234.60%3.46M |
| -Change in payables and accrued expense | -97.06%-3.08M | -63.39%-6.06M | 62.61%-1.14M | 536.10%2.53M | -181.80%-5.89M | 78.56%-1.56M | 39.31%-3.71M | -153.38%-3.04M | 92.31%-579K | 205.45%7.2M |
| -Change in other current assets | 5.52%1.53M | 51.53%6.81M | 72.32%2.25M | 9.95%1.43M | 59.22%1.68M | 73.86%1.45M | 7.65%4.49M | 53.23%1.3M | 141.34%1.3M | -21.59%1.06M |
| -Change in other current liabilities | 239.73%1.45M | 293.47%4.56M | 429.88%3.92M | 426.14%3.22M | -368.12%-1.54M | -36.99%-1.04M | 38.11%-2.36M | -159.39%-1.19M | 15.78%-987K | 156.44%574K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | 860.00%38K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 32.76%-16.8M | 23.64%-78.76M | 51.86%-10.4M | 54.01%-14.78M | -107.51%-28.6M | 29.89%-24.99M | -21.67%-103.15M | -39.06%-21.6M | -8.53%-32.13M | 47.74%-13.78M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 625.30%68.9M | 208.69%58.24M | 61.14%19.07M | 95.65%-6.35M | 25.36%58.62M | -139.07%-13.12M | -197.60%-53.58M | -58.07%11.84M | -998.57%-145.75M | 233.40%46.77M |
| Net PPE purchase and sale | -1,011.18%-8.75M | -98.15%-17.95M | -554.31%-8.95M | -204.14%-6.54M | 30.00%-1.67M | 75.06%-787K | -326.26%-9.06M | 4.80%-1.37M | -756.97%-2.15M | -3,120.27%-2.38M |
| Net investment purchase and sale | 729.75%77.65M | 271.12%76.18M | 112.24%28.02M | 100.14%197K | 22.67%60.29M | -133.57%-12.33M | -178.08%-44.52M | -55.49%13.2M | -971.82%-143.6M | 240.50%49.15M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 625.30%68.9M | 208.69%58.24M | 61.14%19.07M | 95.65%-6.35M | 25.36%58.62M | -139.07%-13.12M | -197.60%-53.58M | -58.07%11.84M | -998.57%-145.75M | 233.40%46.77M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 32.16%-4.99M | -113.94%-27.63M | -31,269.57%-7.22M | -103.33%-6.65M | -216.43%-6.41M | -2,541.86%-7.35M | 889.00%198.13M | -100.78%-23K | 4,751.33%199.88M | -160.49%-2.03M |
| Net issuance payments of debt | 31.03%-4.94M | ---27.48M | ---7.26M | ---- | ---- | ---7.17M | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | --94K | -93.34%147K | --68K | -86.00%28K | -94.22%51K | --0 | -89.62%2.21M | --0 | -95.15%200K | -76.80%882K |
| Net other financing activities | 25.14%-137K | -100.15%-294K | 17.39%-19K | -93.22%13.54M | -368.61%-13.63M | 77.82%-183K | 16,041.25%195.92M | -2,200.00%-23K | --199.68M | -545.01%-2.91M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 32.16%-4.99M | -113.94%-27.63M | -31,269.57%-7.22M | -103.33%-6.65M | -216.43%-6.41M | -2,541.86%-7.35M | 889.00%198.13M | -100.78%-23K | 4,751.33%199.88M | -160.49%-2.03M |
| Net cash flow | ||||||||||
| Beginning cash position | -53.89%41.2M | 86.31%89.36M | -59.91%39.74M | -12.49%67.51M | -4.96%43.9M | 86.31%89.36M | -17.04%47.96M | 206.62%99.15M | 85.46%77.15M | -53.66%46.19M |
| Current changes in cash | 203.65%47.12M | -216.33%-48.16M | 114.89%1.46M | -226.22%-27.77M | -23.73%23.61M | -2,466.63%-45.46M | 520.16%41.39M | -162.64%-9.79M | 337.52%22M | 153.30%30.96M |
| End cash Position | 101.17%88.32M | -53.89%41.2M | -53.89%41.2M | -59.91%39.74M | -12.49%67.51M | -4.96%43.9M | 86.31%89.36M | 86.31%89.36M | 206.62%99.15M | 85.46%77.15M |
| Free cash flow | 0.89%-25.55M | 13.81%-96.71M | 15.76%-19.35M | 37.81%-21.32M | -87.24%-30.27M | 33.56%-25.78M | -29.12%-112.21M | -35.35%-22.97M | -14.83%-34.28M | 38.88%-16.17M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.